BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4736648)

  • 1. The hypocholesterolemic action of eritadenine in the rat.
    Takashima K; Izumi K; Iwai H; Takeyama S
    Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
    [No Abstract]   [Full Text] [Related]  

  • 2. Lentysine: a new hypolipidemic agent from a mushroom.
    Rokujo T; Kikuchi H; Tensho A; Tsukitani Y; Takenawa T; Yoshida K; Kamiya T
    Life Sci; 1970 Apr; 9(7):379-85. PubMed ID: 5463059
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and hypocholesterolemic activities of eritadenine derivatives.
    Okumura K; Matsumoto K; Fukamizu M; Yasuo H; Taguchi Y
    J Med Chem; 1974 Aug; 17(8):846-55. PubMed ID: 4845378
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of suppressed linoleic acid metabolism with the hypocholesterolemic action of eritadenine in rats.
    Sugiyama K; Yamakawa A; Saeki S
    Lipids; 1997 Aug; 32(8):859-66. PubMed ID: 9270978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocholesterolemic action of eritadenine is mediated by a modification of hepatic phospholipid metabolism in rats.
    Sugiyama K; Akachi T; Yamakawa A
    J Nutr; 1995 Aug; 125(8):2134-44. PubMed ID: 7643248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary eritadenine-induced alteration of molecular species composition of phospholipids in rats.
    Sugiyama K; Yamakawa A
    Lipids; 1996 Apr; 31(4):399-404. PubMed ID: 8743052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
    Duncan CH; Best MM
    Atherosclerosis; 1973; 17(2):161-6. PubMed ID: 4709117
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.
    Barrett AM; Thorp JM
    Br J Pharmacol Chemother; 1968 Feb; 32(2):381-91. PubMed ID: 4296427
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of clofibrate on plasma lipids of rat and rabbit.
    Byers SO; Friedman M
    Atherosclerosis; 1970; 11(3):373-82. PubMed ID: 5433083
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA; Sallata P; Kabakjian JR; Cristofalo VJ
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):79-82. PubMed ID: 5344871
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW; Sefranka JA; McIntosh DD
    Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of administration of clofibrate and clofenapate on the content and distribution of ubiquinone in rat tissues.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1974 Mar; 11(1):51-3. PubMed ID: 4435808
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of administration of clofibrate and clofenapate on the activities of glycerolphosphate dehydrogenase and catalase in rat kidney mitochondria.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1973 Sep; 10(3):224-7. PubMed ID: 4792935
    [No Abstract]   [Full Text] [Related]  

  • 16. [Derivatives of para-chlorphenoxyisobutyric acid as hypocholesteremic agents].
    Klebanov BM
    Farmakol Toksikol; 1970; 33(3):324-7. PubMed ID: 5453029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypocholesterolemic activity of analogous compounds related to eritadenine, an active component of shiitake, Lentinus edodes Sing (author's transl)].
    Tensho A; Shimizu I; Takenawa T; Kikuchi H; Rokujo T
    Yakugaku Zasshi; 1974 Jun; 94(6):708-16. PubMed ID: 4472979
    [No Abstract]   [Full Text] [Related]  

  • 18. Dietary eritadenine modifies plasma phosphatidylcholine molecular species profile in rats fed different types of fat.
    Sugiyama K; Yamakawa A; Kawagishi H; Saeki S
    J Nutr; 1997 Apr; 127(4):593-9. PubMed ID: 9109610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eritadenine-induced alterations of plasma lipoprotein lipid concentrations and phosphatidylcholine molecular species profile in rats fed cholesterol-free and cholesterol-enriched diets.
    Shimada Y; Morita T; Sugiyama K
    Biosci Biotechnol Biochem; 2003 May; 67(5):996-1006. PubMed ID: 12834276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC; Connor WE; Armstrong ML; Warner ED
    Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.